Diagnosis, Screening, and Early Detection of Endometrial Cancer
Endometrial cancer, a type of cancer that begins in the lining of the uterus (the endometrium), is the most common gynecologic cancer in the United States. Understanding its signs, the available screening methods, and the diagnostic process is crucial for improving patient outcomes.
Key Takeaways
- Abnormal vaginal bleeding — especially any bleeding after menopause — is the most common and earliest warning sign of endometrial cancer, which is one reason most cases are found while still confined to the uterus.
- Routine, population-wide screening for endometrial cancer isn’t recommended; closer monitoring is reserved instead for women at meaningfully higher risk, such as those with Lynch syndrome.
- An endometrial cancer diagnosis is confirmed by removing a small tissue sample from the uterine lining, usually through an endometrial biopsy, with dilation and curettage (D&C) or hysteroscopy used if more tissue is needed.
- Transvaginal ultrasound and, at times, MRI help evaluate the uterus and the extent of disease, but imaging does not replace tissue sampling for a definitive diagnosis.
- Recognizing symptoms promptly and completing diagnostic testing without delay are the steps within a patient’s control that support early detection of endometrial cancer and better outcomes.
Recognizing Early Signs of Endometrial Cancer
Being aware of the early signs of endometrial cancer matters because prompt recognition often leads to an earlier diagnosis and a better outcome. Most symptoms are noticeable rather than silent, even though it can be tempting to dismiss them, especially around the time of menopause.
Abnormal Vaginal Bleeding
The single most important symptom to watch for is abnormal vaginal bleeding. Once a woman is past menopause, bleeding of any kind — even light spotting — falls outside the norm and calls for prompt evaluation by a doctor. Before menopause, an unusual bleeding pattern can look different: periods running heavier or longer than usual, or spotting that shows up between cycles.
Heavy periods, or any bleeding once menopause has already happened, tend to be the earliest clue that something is wrong, showing up soon enough in the disease’s course that most cases get caught before the cancer has spread beyond the uterus.
Other Potential Symptoms
Less commonly, endometrial cancer can cause pelvic pain or pressure, difficult or painful urination, or pain during sexual intercourse. Vaginal discharge that is not related to a menstrual period — whether watery or blood-tinged — can also be a sign. Any of these symptoms, alone or together with abnormal bleeding, is worth discussing with a doctor.
Understanding Endometrial Cancer Screening
Screening for endometrial cancer works differently than screening for cervical or breast cancer. No population-wide test is recommended for screening; that is largely because endometrial cancer tends to announce itself with a noticeable symptom, most often abnormal bleeding, and gets caught early on its own, without a formal screening program in place.
Who Should Consider Screening?
General population screening is not recommended, but some women face a high enough risk that more active surveillance may be considered. This includes women carrying, or facing a high chance of, Lynch syndrome (also known as hereditary nonpolyposis colorectal cancer) — an inherited condition that raises the odds of several cancers, endometrial cancer among them. Experts have suggested a yearly transvaginal ultrasound for these women, starting as young as age 25. Women with a strong family history of endometrial cancer or a precancerous condition such as endometrial hyperplasia may also be considered for closer monitoring, a decision made together with a doctor.
Current Screening Approaches
The tests that have been studied for endometrial cancer screening — Pap tests, transvaginal ultrasound, and endometrial sampling (biopsy) — remain investigational for that purpose rather than proven, routine screening tools. A Pap test, in particular, is designed to look for cervical cancer, not endometrial cancer; abnormal endometrial cells are sometimes noticed incidentally on a Pap test, but a normal Pap test result does not rule out endometrial cancer. Neither transvaginal ultrasound nor endometrial sampling has been proven, in women without symptoms, to lower how many people die of this disease, and both come with downsides of their own — false results, and occasionally discomfort, bleeding, or infection from the biopsy itself. For this reason, women considering surveillance because of an elevated risk should weigh the specific benefits and risks with their doctor.
The Endometrial Cancer Diagnosis Process
When symptoms raise concern for endometrial cancer, a structured process helps confirm or rule out the disease.
Initial Evaluation and Physical Exam
Diagnosis typically starts with a medical history and physical exam, during which a doctor asks about symptoms, past health, and family history of cancer, and performs a pelvic exam to check the uterus, ovaries, and surrounding organs for anything unusual. A Pap test may be done as part of a routine pelvic exam, but as noted above, it is not designed to detect endometrial cancer, and a normal result does not rule it out.
Referral to a Specialist
If the initial evaluation raises concern, a woman is typically referred to a gynecologic oncologist, a specialist in cancers of the female reproductive system, for further testing and, if cancer is confirmed, treatment planning.
Key Diagnostic Methods for Endometrial Cancer
Confirming endometrial cancer requires removing a tissue sample from the uterine lining for examination under a microscope; imaging can support this process, but tissue sampling is what makes the diagnosis.
Endometrial Biopsy and D&C
The most common diagnostic procedure is an endometrial biopsy, an outpatient procedure in which a thin, flexible tube is passed through the cervix to gently draw a small tissue sample from the endometrium for a pathologist to examine. If the biopsy result is unclear or does not provide enough tissue, dilation and curettage (D&C) may be done instead: performed under anesthesia, the cervix is gently dilated and a curette is used to scrape a larger tissue sample from the uterine lining. In some cases, a doctor may also use hysteroscopy — a thin, lighted scope passed through the cervix — to look directly inside the uterus and collect a tissue sample from any abnormal area.
Imaging Techniques (Ultrasound, MRI)
Imaging tests do not provide a definitive diagnosis on their own, but they help evaluate the uterus and, once cancer is confirmed, the extent of disease. A transvaginal ultrasound, in which a probe placed in the vagina is used to create images of the uterus with sound waves, is often the first imaging test used; it can measure the thickness of the endometrium, and an unusually thick lining, especially after menopause, can be a sign worth investigating further. MRI may also be used to look more closely at the uterus and nearby structures, giving doctors more detail to work with when staging the cancer and planning treatment.
Why Early Detection Matters for Outcomes
Catching and treating endometrial cancer before it has moved past the uterus generally leads to a more favorable outlook than treatment started after it has spread elsewhere, which is why prompt evaluation of any abnormal bleeding matters. Because this cancer usually causes an early symptom and is usually diagnosed at an early stage, it is often treatable with surgery alone. The specific survival statistics by stage are covered in detail on our survival rate page for endometrial cancer; what matters here is that recognizing symptoms promptly, following through on recommended diagnostic tests, and starting treatment without unnecessary delay are the steps within a patient’s control that support the best possible outcome.
Frequently Asked Questions
What are the primary risk factors for endometrial cancer?
Factors linked with a higher risk of endometrial cancer include obesity, metabolic syndrome, and type 2 diabetes; older age, especially after menopause; taking estrogen alone (without progesterone) after menopause, or taking tamoxifen for breast cancer; never having given birth, early menstruation, or late menopause; polycystic ovary syndrome; and a personal or family history of endometrial hyperplasia, endometrial cancer, or Lynch syndrome. Having one or more of these factors does not mean a woman will develop endometrial cancer — it means her doctor may want to talk through whether closer monitoring makes sense. Our causes and risk factors page for endometrial cancer covers each of these in more detail.
Is a Pap test effective for detecting endometrial cancer?
No. A Pap test is designed to screen for abnormal cells on the cervix, not the endometrium, so it is not a reliable way to detect endometrial cancer. Endometrial cells are occasionally noticed on a Pap test, but a normal result does not rule out endometrial cancer. Abnormal vaginal bleeding or other concerning symptoms call for a specific evaluation, such as an endometrial biopsy, rather than relying on a Pap test result.
How long does it typically take to get an endometrial cancer diagnosis?
There is no fixed timeline, since it depends on how quickly tests can be scheduled and how soon results come back. In general, an initial evaluation and any needed referral happen within days to about a week, and an endometrial biopsy can often be done at that first visit or shortly after; if a D&C or additional imaging is needed, that can add some time for scheduling. A doctor’s office can give the most accurate estimate for a specific situation.
Sources
